Skip to main content
OpenTrials
Completed

NCT Number: NCT05196997

The De-Morton Mobility Index Turkish Version in Intensive Care Patients

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Care Function Mobility

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

İlknur Naz Gürşan

Izmir, 35620, Turkey (Türkiye)

About this study

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.

Patients aged 18 years and over who were discharged from the ICU were included in our study.

We used De-Morton Mobility Index, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test for convergent validity. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • staying in intensive care unit for at least 24 hours
  • able to cooperate
  • being clinically stable for mobility assessment

Exclusion criteria

  • the presence of neurological disease
  • the presence of orthopedic problems such as fractures
  • the presence of metastases
  • the presence of cardiorespiratory instability

Treatment and study plan

Mobility and Functional Assessments

Other

The first evaluation was made on the day the patient was discharged from the intensive care unit. DEMMI, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test were performed to the patient, respectively.

De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.

Primary outcomes

  1. Mobility Assessment

    Time frame: 15 minutes

    De Morton Mobility Index: It consists of a total of 15 mobility items. The total score ranges from 0-100, with 0 indicating poor mobility and 100 indicating high mobility

Secondary outcomes

  1. Functional independence measurement

    Time frame: 5 minutes

    The Barthel index: It includes 10 items: nutrition, bathroom, personal care, dressing, toilet use, mobility on flat surfaces (immobile, wheelchair use, walking with assistance or independently), transfer (transfer from wheelchair to bed and vice versa), climbing stairs, bowel and bladder continence. It is scored between 0-100. 0; fully independent, 100; means fully independent.

  2. Assessment of daily living activities

    Time frame: 5 minutes

    Katz Index: The index includes basic parameters of daily living activities such as bathing, dressing, toilet, transfer, urine and stool control, nutrition. The scoring of the index varies in the range of 0-6. Higher scores indicate higher independence

  3. Muscle Strength

    Time frame: 10 minutes

    Medical Research Council scale: It includes muscle strength test of six muscle groups. Scoring ranges from 0 to 5 in each muscle group. The maximum score is 60, and a score below 48 indicates significant muscle weakness

Sponsors and collaborators

Lead sponsor

Izmir Katip Celebi University

Other

Registry information

Official study title

Construct Validity and Test-Retest Reliability of The De-Morton Mobility Index Turkish Version in Intensive Care Patients

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jan 19, 2022
Registry last updated
Jan 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.